By Colin Kellaher
Abbott Laboratories on Wednesday said the U.S. Food and Drug Administration gave a green light to the company’s Aveir system, making it the world’s first approved dual-chamber leadless pacemaker.
The Abbott Park, Ill., maker of healthcare products said the approval significantly increases access to leadless pacing for millions…
Read the full article here
